Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | The role of myeloma B-cells & pre-plasma cell progenitors in disease relapse following therapy

Rodger Tiedemann, MD, PhD, FRACP, FRCPA, Princess Margaret Cancer Centre, Toronto, Canada, shares some insights into a study which evaluated the role of myeloma B-cells and pre-plasma progenitor cells in disease relapse using whole exome sequencing (WES) and extensive mutational profiling. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


Janssen, AbbVie